INPPL1 and PIK3R2 are known regulators of PI3K/AKT signaling, but their effect on downstream signaling in BC remains unclear and neither gene has been linked to resistance to PI3K/AKT inhibitors previously. Here, INPPL1 is linked to breast cancer.